Science has progressed at an astonishing pace during the pandemic. Six months ago, there were a handful of vaccine candidates in clinical trials. Today, 13 vaccines have been approved and 29 are in Phase 2 or 3 trials. Despite the incredible achievement of proceeding from scratch to having so many approved vaccines within a year, the final challenge remains: producing enough doses to vaccinate the world’s population, and distributing vaccines in a fair and equitable manner because till everyone is vaccinated the danger of recurrence of coronavirus would not be over. (Read More)
Be the first to comment